Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanley, A. J.
Right arrow Articles by Zinman, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanley, A. J.
Right arrow Articles by Zinman, B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 20, Issue 9 1408-1415, Copyright © 1997 by American Diabetes Association


ARTICLES

Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM

AJ Hanley, SB Harris, XJ Gao, J Kwan and B Zinman
Samual Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto, Ontario, Canada.

OBJECTIVE: To better understand the relationship between leptin and the anthropometric and physiological variables associated with diabetes, we measured this protein in an isolated Canadian aboriginal population with very high rates of NIDDM. RESEARCH DESIGN AND METHODS: There were 728 individuals aged 10-79 years who participated in a population-based survey to determine the prevalence of NIDDM and its associated risk factors. Fasting blood samples for glucose, insulin, triglyceride, and leptin were collected; a 75-g oral glucose tolerance test was administered and a second blood sample drawn after 120 min. Height, weight, and waist and hip circumference were determined, and percent body fat was estimated using biological impedance analysis. Fitness level was assessed in a subsample of individuals using a validated submaximal step test. The relationship between serum leptin and the other variables was assessed using Spearman's correlation coefficients and multiple linear regression. RESULTS: Serum leptin concentration was strongly correlated with adiposity, and levels were substantially higher in female subjects in all age-groups. For male subjects, percent body fat, fasting insulin level, and waist circumference were significant independent predictors of log serum leptin concentration in a multiple linear regression model (R2 = 0.582). For female subjects, these variables plus glucose tolerance status were included in the final model (R2 = 0.633). Fitness level, when included with the main effects of the above models, was a significant predictor for male subjects only. CONCLUSIONS: In an isolated aboriginal community with high rates of diabetes, we found significant independent relationships between leptin and percent body fat and between leptin and fasting insulin. As documented in other populations, the higher leptin concentration among female subjects may reflect differential leptin production from different adipose tissue beds, or leptin resistance. Independent relationships also existed among leptin and glucose tolerance status in female subjects and fitness level in male subjects.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
S. H. Ley, S. B. Harris, P. W. Connelly, M. Mamakeesick, J. Gittelsohn, R. A. Hegele, R. Retnakaran, B. Zinman, and A. J.G. Hanley
Adipokines and Incident Type 2 Diabetes in an Aboriginal Canadian Population: The Sandy Lake Health and Diabetes Project
Diabetes Care, July 1, 2008; 31(7): 1410 - 1415.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. V. Silha, B.L. G. Nyomba, W. D. Leslie, and L. J. Murphy
Ethnicity, Insulin Resistance, and Inflammatory Adipokines in Women at High and Low Risk for Vascular Disease
Diabetes Care, February 1, 2007; 30(2): 286 - 291.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
R. Retnakaran, A. J.G. Hanley, P. W. Connelly, S. B. Harris, and B. Zinman
Cigarette smoking and cardiovascular risk factors among Aboriginal Canadian youths
Can. Med. Assoc. J., October 11, 2005; 173(8): 885 - 889.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. E Ruhl, J. E Everhart, J. Ding, B. H Goodpaster, A. M Kanaya, E. M Simonsick, F. A Tylavsky, and T. B Harris
Serum leptin concentrations and body adipose measures in older black and white adults
Am. J. Clinical Nutrition, September 1, 2004; 80(3): 576 - 583.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. J.G. Hanley, P. W. Connelly, S. B. Harris, and B. Zinman
Adiponectin in a Native Canadian Population Experiencing Rapid Epidemiological Transition
Diabetes Care, December 1, 2003; 26(12): 3219 - 3225.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. M. Kriska, A. J.G. Hanley, S. B. Harris, and B. Zinman
Physical Activity, Physical Fitness, and Insulin and Glucose Concentrations in an Isolated Native Canadian Population Experiencing Rapid Lifestyle Change
Diabetes Care, October 1, 2001; 24(10): 1787 - 1792.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. E Ruhl and J. E Everhart
Leptin concentrations in the United States: relations with demographic and anthropometric measures
Am. J. Clinical Nutrition, September 1, 2001; 74(3): 295 - 301.
[Abstract] [Full Text]


Home page
CMAJHome page
T. K. Young, J. Reading, B. Elias, and J. D. O'Neil
Type 2 diabetes mellitus in Canada's First Nations: status of an epidemic in progress
Can. Med. Assoc. J., September 1, 2000; 163(5): 561 - 566.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
R. A. HEGELE, H. CAO, S. B. HARRIS, B. ZINMAN, A. J. HANLEY, and C. M. ANDERSON
Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians
Physiol Genomics, June 29, 2000; 3(1): 39 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. A. Hegele, H. Cao, S. B. Harris, B. Zinman, A. J. G. Hanley, and C. M. Anderson
Peroxisome Proliferator-Activated Receptor-{gamma}2 P12A and Type 2 Diabetes in Canadian Oji-Cree
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2014 - 2019.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. A. Hegele, H. Cao, S. B. Harris, A. J. G. Hanley, B. Zinman, and P. W. Connelly
The Private Hepatocyte Nuclear Factor-1{alpha} G319S Variant Is Associated With Plasma Lipoprotein Variation in Canadian Oji-Cree
Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 217 - 222.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.